Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK

Author:

Dyer Amy,Kirby Mike,White Isabel D,Cooper Alison MichelleORCID

Abstract

ObjectivesErectile dysfunction (ED) is known to be a common consequence of radical treatment for prostate cancer (PCa) but is often under-reported and undertreated. This study aimed to explore how ED in patients with PCa is managed in real-life clinical practice, from the perspective of patients and healthcare professionals (HCPs).Design and settingThis is a UK-wide cross-sectional survey of men with ED after treatment for PCa which covered assessment and discussion of erectile function, provision of supportive care and satisfaction with management. Parallel surveys of primary and secondary HCPs were also conducted.ResultsResponses were received from 546 men with ED after PCa treatment, 167 primary (general practitioners and practice nurses) and 94 secondary care HCPs (urologists and urology clinical nurse specialists). Survey findings revealed inadequate management of ED in primary care, particularly underprescribing of effective management options. A fifth of men (21%) were not offered any ED management, and a similar proportion (23%) were not satisfied with the way HCPs addressed their ED concerns. There was poor communication between HCPs and men, including failure to initiate discussions about ED and/or involve partners, with 12% of men not told that ED was a risk factor of PCa treatment. These issues seemed to reflect poor access to effective ED management or services and lack of primary HCP confidence in managing ED, as well as confusion over the roles and responsibilities among both HCPs and men.ConclusionsThis study confirms the need for better support for men from HCPs and more tailored and timely access to effective ED management after treatment for PCa. A clearly defined pathway is required for the discussion and management of ED, starting from the planning stage of PCa treatment. Improved adherence to ED management guidelines and better education and training for primary care HCPs are areas of priority.

Funder

Prostate Cancer UK

Publisher

BMJ

Subject

General Medicine

Reference52 articles.

1. International Agency for Research on Cancer. All cancers fact sheet . Globocan 2018, 2018. Available: http://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf [Accessed 15 Aug 2019].

2. International Agency for Research on Cancer. Prostate cancer fact sheet . Globocan 2018, 2018. Available: http://gco.iarc.fr/today/data/factsheets/cancers/27-Prostate-fact-sheet.pdf [Accessed 15 Aug 2019].

3. International Agency for Research on Cancer. United Kingdom fact sheet . Globocan 2018, 2018. Available: http://gco.iarc.fr/today/data/factsheets/populations/826-united-kingdom-fact-sheets.pdf [Accessed 15 Aug 2019].

4. Cancer Research UK . Prostate cancer incidence statistics - By age (2014 - 2016). Cancer Res. UK, 2019. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence [Accessed 15 Aug 2019].

5. Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3